Morguard Corporation Announces Filing of Final Base Shelf Prospectus

Morguard Corporation Announces Filing of Final Base Shelf Prospectus

Canada NewsWire

MISSISSAUGA, ON, Nov. 23, 2017 /CNW/ - Morguard Corporation (“Morguard”), (TSX: MRC) announced today that it has filed a (final) base shelf prospectus with the securities regulatory authorities in each of the provinces and territories of Canada, except Quebec. The base shelf prospectus is valid for a 25-month period, during which Morguard may offer debt securities having an aggregate offering price of up to $600 million. Any issue of securities under the base shelf prospectus will require the filing of a prospectus supplement that will include specific terms of the securities being offered.

This news release does not constitute an offer to sell securities, nor is it a solicitation of an offer to buy securities in any jurisdiction. This news release does not constitute an offer of securities for sale in the United States and the securities referred to in this news release may not be offered or sold in the United States absent a registration or an exemption from registration.

About Morguard Corporation

Morguard Corporation is a real estate company, with total assets owned and under management valued at $22.0 billion. Morguard owns a diversified portfolio of 208 multi-suite residential, retail, office, industrial and hotel properties comprised of 18,129 residential suites, approximately 16.5 million square feet of commercial leasable space and 5,557 hotel rooms. Morguard also currently owns a 54.1% interest in Morguard Real Estate Investment Trust, a 46.9% effective interest in Morguard North American Residential Real Estate Investment Trust and a 55.9% effective interest in Temple Hotels Inc. Morguard also provides advisory and management services to institutional and other investors. For more information, visit Morguard’s website at www.morguard.com.

Forward–Looking Statements

This press release contains forward-looking information within the meaning of applicable securities legislation, which reflects Morguard’s current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Morguard’s control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to the factors discussed in Morguard’s current Annual Information Form and MD&A, which are both available on Morguard’s website at www.Morguard.com and on SEDAR at www.sedar.com. Morguard does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

SOURCE Morguard Corporation

View original content: http://www.newswire.ca/en/releases/archive/November2017/23/c4473.html

Phivida Holdings Inc. Receipt for Filing of Final Prospectus

Phivida Holdings Inc. Receipt for Filing of Final Prospectus

Canada NewsWire

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

VANCOUVER, Nov. 23, 2017 /CNW/ – Phivida Holdings Inc. (“Phivida“) is pleased to announce that it has filed and obtained a receipt for its final long form prospectus dated November 21, 2017 (the “Prospectus“) from the securities regulatory authorities in British Columbia and Ontario.

Phivida Organics (CNW Group/Phivida Organics)

The Prospectus qualifies Phivida’s Initial Public Offering (the “IPO“) and the distribution of a minimum of 1,250,000 units of Phivida (each, a “Unit“) and a maximum of 12,500,000 Units (the “Offering“), at a price of $0.40 per Unit. Each Unit consists of one common share (each, a “Common Share“) one-half of one Common Share purchase warrant (each whole warrant, a “Warrant“). Each Warrant is exercisable at a price of $0.75 per Common Share for a period of 24 months from the closing date of the Offering.

The Units are being offered for sale by Canaccord Genuity Corp. as lead agent and sole bookrunner, together with Mackie Research Capital Corp. and Haywood Securities Inc. (collectively, the “Agents“) on a best efforts basis pursuant to an agency agreement among the Company and the Agents dated November 21, 2017. Phivida has granted the Agents an over-allotment option, exercisable for a period expiring 30 days from the closing of the Offering, for up to such number of additional Units as is equal to 15% of the Units sold pursuant to the Offering.

The Warrants are subject to an acceleration clause whereby if at any time after the Common Shares are listed on the Canadian Securities Exchange (“CSE“) the closing trading price of the Common Shares is greater than $1.00 for at least 20 consecutive trading days, Phivida shall have the right to accelerate the expiry date of the Warrants with a minimum of 20 days’ notice to shareholders, issued by way of press release.

In connection with the Offering, Phivida has received conditional approval from the CSE for the listing of the Common Shares, subject to the completion of customary requirements of the CSE, including the receipt of all required final documentation. Once final approval is received, the Common Shares will commence trading under the symbol “VIDA”.

A copy of the Prospectus is available on SEDAR (www.sedar.com).

No securities regulatory authority has either approved or disapproved of the contents of this news release. The common shares have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States, or to or for the account or benefit of any person in the United States, absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any common shares in the United States, or in any other jurisdiction in which such offer, solicitation or sale would be unlawful.

Phivida Holdings Inc.
Phivida (pronounced “fiii-vee-daa”) is a premiere brand of cannabidiol (“CBD“) infused functional foods and beverages and clinical CBD products, poised for global distribution. Using nanoencapsulation technology, Phivida converts lipid based cannabinoids into water soluble delivery format enhancing prospective bioavailability and timed released within the body. Phivida’s nanoencapsulated CBD is infused into CBD beverages which contain a proprietary blend of phytonutraceuticals targeting key health benefits for which cannabinoids are widely studied. Celebrating; Health and Wellness, In Harmony™, Phivida’s mission is to be a leader in the alternative health sector and the quality standard in the global CBD infused foods, beverages and clinical products market.

For more information on Phivida products visit www.phivida.com. To participate in the initial offering, contact the syndicate agents via the contact information listed below.

Forward-Looking Statements

This press release contains “forward-looking information” within the meaning of Canadian securities laws, which may include, but are not limited to statements relating to the trading date of the Common Shares. Such forward-looking information reflects Phivida’s views with respect to future events and is subject to risks, uncertainties and assumptions, including those set out in the Prospectus, the risk that closing of the Offering will be delayed and the risk that the Offering may not be completed. Phivida does not undertake to update forward-looking statements or forward-looking information, except as required by law.

SOURCE Phivida Organics

View original content with multimedia: http://www.newswire.ca/en/releases/archive/November2017/23/c3681.html

Director authorization to purchase Ecopetrol shares

Director authorization to purchase Ecopetrol shares

Canada NewsWire

BOGOTÁ, Colombia, Nov. 23, 2017 /CNW/ — Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) reports that its Board of Directors, meeting in ordinary session on November 16, 2017, authorized Dr. Felipe Bayón Pardo, Chairman and Company Legal Representative, to purchase up to the equivalent of COP$ 15,000,000 (fifteen million Colombian pesos) of Ecopetrol shares.

Ecopetrol Logo. (PRNewsFoto/Ecopetrol S.A.)

This transaction will become effective within eight (8) business days following the date of approval and after the publication of the 2018 investment plan, and according to Dr. Felipe Bayón, is not for speculative purposes.

This release contains statements that may be considered forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. All forward-looking statements, whether made in this release or in future filings or press releases or orally, address matters that involve risks and uncertainties, including in respect of the Company’s prospects for growth and its ongoing access to capital to fund the Company’s business plan, among others. Consequently, changes in the following factors, among others, could cause actual results to differ materially from those included in the forward-looking statements: market prices of oil & gas, our exploration and production activities, market conditions, applicable regulations, the exchange rate, the Company’s competitiveness and the performance of Colombia’s economy and industry, to mention a few. We do not intend, and do not assume any obligation to update these forward-looking statements.

For further information contact:
Capital Markets Manager
María Catalina Escobar
Telephone: +571-234-5190
Email: investors@ecopetrol.com.co

Media Relations (Colombia)
Jorge Mauricio Tellez
Telephone: + 571-234-4329
Email: mauricio.tellez@ecopetrol.com.co

View original content:http://www.prnewswire.com/news-releases/director-authorization-to-purchase-ecopetrol-shares-300561419.html

SOURCE Ecopetrol S.A.

View original content: http://www.newswire.ca/en/releases/archive/November2017/23/c5542.html